AI Medical Technology nets SEK10.8 million to accelerate Dermalyser AI-driven diagnostic support tool for skin cancer
· Northern CapSek Ventures takes part in oversubscribed investment round · First prospective clinical trials showing unmatched levels of sensitivity and specificity · Funds will finalise CE marking and European commercialisation · FDA approval planning initiated as company eyes US market Stockholm, Sweden, Jan 24, 2023. Swedish Artificial Intelligence start-up AI Medical Technology announces it has completed a heavily oversubscribed SEK10.8 million fundraise. The new funds will be used initially to expand the company’s clinical trial program for its Dermalyser AI-driven support